Setting standards for the prevention and management of travellers' diarrhoea in elite athletes: An audit of one team during the Youth Commonwealth Games in India

British Journal of Sports Medicine

Volumn 43, Issue 13, 2009, Pages 1045-1048

  Tillett, E ^a   Loosemore, M ^b  

^a Olympic Medical Institute   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTI-INFECTIVE AGENTS; ATHLETES; CIPROFLOXACIN; CLINICAL PROTOCOLS; DIARRHEA; ENGLAND; HEALTH PROMOTION; HUMANS; HYGIENE; INCIDENCE; INDIA; MEDICAL AUDIT; TRAVEL;

EID: 73349120564     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2009.063396     Document Type: Article

References (21)

1. Milne CJ, Shaw MTM. Travelling to China for the Beijing 2008 Olympic Games. Br J Sports Med 2008;42:321-6.
2. Young M, Fricker P, Maughan R, et al. The travelling athlete: issues relating to the Commonwealth Games, Malaysia, 1998. Br J Sports Med 1998;32:77-81.
3. Simon LM, Rubin AL. Traveling with the Team. Curr Sports Med Rep 2008;7:138-43.
4. Hill DR, Ryan ET. Management of travellers' diarrhoea. BMJ 2008;337:863-7.
5. DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs 2006;66:303-14.
6. Ericsson CD. Travellers' diarrhoea. Int J Antimicrob Agents 2003;21:116-24.
7. Plourde P. Statement of travellers' diarrhoea, an advisory committee statement, committee to advise on tropical medicine and travel. Can Commun Dis Rep 2001;27(ACS-3):1-9.
8. Tsai WC, Hsu CC, Chen HC, et al. Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation. Eur J Pharmacol 2009;607:23-6.
9. Damuth E, Heidelbaugh J, Malani PN, et al. An elderly patient with fluoroquinoloneassociated achilles tendinitis. Am J Geriatr Pharmacother 2008;6:264-8.
10. Bravo AR, Stoll R, Bürr P, et al. Fluorquinolone associated tendon rupture. Praxis (Bern 1994) 2008;97:1159-67.
11. Kayabas U, Yetkin F, Firat AK, et al. Ciprofloxacin-induced urticaria and tenosynovitis: a case report. Chemotherapy 2008;54:288-90.
12. Tsai WC, Hsu CC, Chen HC, et al. Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation. Eur J Pharmacol 2009;607:23-6.
13. DuPont HL. Systematic review: prevention of travellers' diarrhoea. Aliment Pharmacol Ther 2008;27:741-51.
14. Greenwood Z, Black J, Weld L, et al. Gastrointestinal infection among travelers globally. J Travel Med 2008;15:221-8.
15. Karistinos A, Paulos LE. "Ciprofloxacin-induced" bilateral rectus femoris tendon rupture. Clin J Sport Med 2007;17:406-7.
16. Tsai WC, Hsu CC, Tang FT, et al. Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum 2008;58:1657-63.
17. Ericsson CD. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea. Drug Saf 2006;29:201-7.
18. DuPont HL, Jiang ZD, Okhuysen PC, et al. A randomized, double-blind, placebocontrolled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005;142:805-12.
19. Taylor DN, Bourgeois AL, Ericsson CD, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 2006;74:1060-6.
20. Larsen CS, Black FT. Traveller's diarrhea. Ugeskr Laeger 2005;167:4068-72.
21. Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006;6:374-82.